About Butyrophilin-like protein 9
Butyrophilin-like protein 9 (BTNL9) is a protein
from Homo sapiens identified by UniProt accession
Q6UXG8, 535 residues long.
MolForge cross-references it against 0 known binders and
60 disease associations.
Target properties
| Protein name | Butyrophilin-like protein 9 |
| UniProt accession | Q6UXG8 |
| Gene | BTNL9 |
| Organism | Homo sapiens |
| Length | 535 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (60)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.24
- lipoprotein measurement · score 0.21
- high density lipoprotein cholesterol measurement · score 0.14
- cutaneous melanoma · score 0.12
- lung adenocarcinoma · score 0.08
- ulnar-mammary syndrome · score 0.07
- Pneumothorax · score 0.06
- neoplasm · score 0.05
- non-small cell lung carcinoma · score 0.04
- breast carcinoma · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6UXG8-F1 | alphafold | PREDICTED | 83.71 | — |
Amino-acid sequence (535 residues)
MVDLSVSPDS LKPVSLTSSL VFLMHLLLLQ PGEPSSEVKV LGPEYPILAL VGEEVEFPCH LWPQLDAQQM EIRWFRSQTF NVVHLYQEQQ ELPGRQMPAF RNRTKLVKDD IAYGSVVLQL HSIIPSDKGT YGCRFHSDNF SGEALWELEV AGLGSDPHLS LEGFKEGGIQ LRLRSSGWYP KPKVQWRDHQ GQCLPPEFEA IVWDAQDLFS LETSVVVRAG ALSNVSVSIQ NLLLSQKKEL VVQIADVFVP GASAWKSAFV ATLPLLLVLA ALALGVLRKQ RRSREKLRKQ AEKRQEKLTA ELEKLQTELD WRRAEGQAEW RAAQKYAVDV TLDPASAHPS LEVSEDGKSV SSRGAPPGPA PGHPQRFSEQ TCALSLERFS AGRHYWEVHV GRRSRWFLGA CLAAVPRAGP ARLSPAAGYW VLGLWNGCEY FVLAPHRVAL TLRVPPRRLG VFLDYEAGEL SFFNVSDGSH IFTFHDTFSG ALCAYFRPRA HDGGEHPDPL TICPLPVRGT GVPEENDSDT WLQPYEPADP ALDWW
Explore Butyrophilin-like protein 9 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets